This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Sanofi SA
Sanofi SA, a global healthcare leader headquartered in Switzerland (CH), is renowned for its innovative contributions to the pharmaceutical industry. Founded in 2004 through the merger of Sanofi-Synthélabo and Aventis, the company has established a strong presence in key operational regions, including Europe, North America, and Asia. Specialising in prescription medicines, vaccines, and consumer healthcare products, Sanofi is committed to addressing complex health challenges. Its core offerings include diabetes care solutions, rare disease treatments, and vaccines, distinguished by their cutting-edge research and development. With a robust market position, Sanofi has achieved notable milestones, such as being a top player in the global vaccine market and consistently ranking among the leading pharmaceutical companies worldwide.
DitchCarbon Score
How does Sanofi SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sanofi SA's score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sanofi SA, headquartered in Switzerland (CH), currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Sanofi, the company is engaged in various climate initiatives, although no specific reduction targets or achievements have been documented. Sanofi has committed to several industry-standard climate initiatives, including the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are cascaded from the parent organization. However, detailed emissions data and specific reduction targets have not been disclosed. In the absence of concrete emissions figures, it is important to note that Sanofi is actively participating in climate commitments aimed at reducing its carbon footprint and enhancing sustainability practices within the pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2011 | 2012 | 2013 | 2015 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 545,114,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 677,549,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | 0,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sanofi SA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
